Konfoong Bioinformation Tech Co., Ltd.
PrivateLast Round
Series C
Jul 12, 2022
Total Funding Raised
$29.1M
Company Overview
Konfoong Bioinformation Tech Co., Ltd. operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a Series C round in July 2022.
Konfoong Bioinformation Tech Co., Ltd. is a medical technology company that develops and manufactures digital pathology systems, including slide scanners, telepathology platforms, and AI-powered diagnostic software.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, EHR & EMR
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Konfoong Bioinformation Tech Co., Ltd. Comparables
Compare Konfoong Bioinformation Tech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Shengqiang Technology Co., Ltd. | 86% | |
| OptraSCAN | 83% | |
| 3DHISTECH | 82% |
For institutional investors. Book with your work email.
Konfoong Bioinformation Tech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 12, 2022 | ||||
| Series B | Apr 1, 2020 | ||||
| Series A | Aug 1, 2016 |
For institutional investors. Book with your work email.
Konfoong Bioinformation Tech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yinxinggu Capital | Series B |
| Zhejiang Xinganxian Media Investment Co., Ltd. | Series A |
| Shengshan Asset Management | Series C |
| Intel Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2022
$15M round led by Shengshan Asset Management.
- Apr 1, 2020
$14M round led by Intel Capital
For institutional investors. Book with your work email.
Konfoong Bioinformation Tech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Konfoong Bioinformation Tech Co., Ltd.'s valuation, stock price, and market status.
Is Konfoong Bioinformation Tech Co., Ltd. a public or private company?
Konfoong Bioinformation Tech Co., Ltd. is a private company.
What is the current stock price of Konfoong Bioinformation Tech Co., Ltd.?
Konfoong Bioinformation Tech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Konfoong Bioinformation Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Konfoong Bioinformation Tech Co., Ltd. worth (valuation)?
Valuation information for Konfoong Bioinformation Tech Co., Ltd. is not publicly available.
Can I buy Konfoong Bioinformation Tech Co., Ltd. stock?
Konfoong Bioinformation Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Konfoong Bioinformation Tech Co., Ltd.'s last funding round?
Konfoong Bioinformation Tech Co., Ltd.'s most recent funding round was Series C on July 12, 2022.
Who are the main investors in Konfoong Bioinformation Tech Co., Ltd.?
Key investors in Konfoong Bioinformation Tech Co., Ltd. include Shengshan Asset Management, Intel Capital.
Will Konfoong Bioinformation Tech Co., Ltd. IPO soon?
No public IPO plans have been announced for Konfoong Bioinformation Tech Co., Ltd..
How can I track Konfoong Bioinformation Tech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Konfoong Bioinformation Tech Co., Ltd.'s shares on secondary markets.